Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04184362 · ClinicalTrials.gov registry record · NA
Empower Opioid Misuse & Chronic Pain
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04184362 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 10 participants.
The verdict
NCT04184362, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study evaluates the effects of peripheral nerve stimulation on opioid craving and use and pain in participants with chronic non-cancer pain (NCP) and opioid misuse. Participants will be randomized to receive the active or sham control treatment for the duration of the study.
Interventions
- DEVICE Empower Neuromodulation System Transcutaneous Electrical Nerve Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2022-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04184362
The ClinicalTrials.gov registry entry for NCT04184362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Empower Neuromodulation System Transcutaneous Electrical Nerve Stimulation is the first listed.
NCT04184362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04184362 about?
NCT04184362 is a clinical study titled "Empower Opioid Misuse & Chronic Pain". This study evaluates the effects of peripheral nerve stimulation on opioid craving and use and pain in participants with chronic non-cancer pain (NCP) and opioid misuse. Participants will be randomized to receive the active or sham control treatment for the duration of the study.
What is the current status of trial NCT04184362?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-11-20. Estimated completion is 2022-03-21.
What interventions are being tested in trial NCT04184362?
The interventions under investigation include: Empower Neuromodulation System Transcutaneous Electrical Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04184362?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.